Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1190561016 | Pyrimethamine+dapsone 12.5mg/100mg tablet (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3470803016 | Product containing pyrimethamine 12.5 mg and dapsone 100 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3489312014 | Product containing pyrimethamine 12.5 mg and dapsone 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3500758012 | Pyrimethamine 12.5 mg and dapsone 100 mg oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3566702015 | Product containing only pyrimethamine 12.5 mg and dapsone 100 mg/1 each oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3566703013 | Product containing only pyrimethamine 12.5 mg and dapsone 100 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3682460018 | Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3682461019 | Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3682462014 | Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 465614011 | Pyrimethamine+dapsone 12.5mg/100mg tablet | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 718193014 | Pyrimethamine+dapsone 12.5mg/100mg tablet (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Is a | Dapsone and pyrimethamine only product in oral dose form | true | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Plays role | Antileprotic therapeutic role | true | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Plays role | Antimalarial therapeutic role | true | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Is a | Pyrimethamine-containing product | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Is a | Dapsone-containing product | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has active ingredient | Pyrimethamine | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has active ingredient | Dapsone | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Is a | Dapsone- and pyrimethamine-containing product | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Is a | Dapsone-containing product in oral dose form | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Is a | Pyrimethamine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has active ingredient | Dapsone | false | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has BoSS | Dapsone | false | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has active ingredient | Pyrimethamine | false | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has BoSS | Pyrimethamine | false | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has BoSS | Pyrimethamine | true | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has BoSS | Dapsone | true | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has presentation strength numerator value | 100 | false | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has active ingredient | Pyrimethamine | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has active ingredient | Dapsone | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Is a | Dapsone- and pyrimethamine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has precise active ingredient | Pyrimethamine | true | Inferred relationship | Some | 1 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Has precise active ingredient | Dapsone | true | Inferred relationship | Some | 2 | |
| Dapsone 100 mg and pyrimethamine 12.5 mg oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR